APA (7th ed.) Citation

Lassen, M., Colacci, M., Pareek, M., Lee, S., Gislason, G. H., Fralick, M., & Biering-Sorensen, T. (2024). ASSOCIATION BETWEEN SGLT2 INHIBITOR USE AND CHANGE IN HEMOGLOBIN AMONG ADULTS WITH DIABETES. Journal of the American College of Cardiology (JACC), 83(13), 1903. https://doi.org/10.1016/S0735-1097(24)03893-2

Chicago Style (17th ed.) Citation

Lassen, Mats, Michael Colacci, Manan Pareek, Stephanie Lee, Gunnar H. Gislason, Michael Fralick, and Tor Biering-Sorensen. "ASSOCIATION BETWEEN SGLT2 INHIBITOR USE AND CHANGE IN HEMOGLOBIN AMONG ADULTS WITH DIABETES." Journal of the American College of Cardiology (JACC) 83, no. 13 (2024): 1903. https://doi.org/10.1016/S0735-1097(24)03893-2.

MLA (9th ed.) Citation

Lassen, Mats, et al. "ASSOCIATION BETWEEN SGLT2 INHIBITOR USE AND CHANGE IN HEMOGLOBIN AMONG ADULTS WITH DIABETES." Journal of the American College of Cardiology (JACC), vol. 83, no. 13, 2024, p. 1903, https://doi.org/10.1016/S0735-1097(24)03893-2.